DBV Technologies S.A. | TalkMarkets

Latest Posts

DBV Receives Non Approval Letter From FDA For Peanut Allergy Patch

Article By: The Fly

Tuesday, August 4, 2020 5:25 AM EDT

DBV Technologies announced that the Food and Drug Administration has issued a Complete Response Letter regarding the company's Biologics License Application for Viaskin Peanut.

In this article: DBVT

Read

DBV Jumps 41% To $9.96 After Update On Viaskin Peanut Filing

Article By: The Fly

Wednesday, February 13, 2019 5:49 PM EDT

Shares of DBV Technologies jumped after the company said that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut is anticipated in the third quarter of 2019.

In this article: DBVT Also: AIMT

Read

DBV Technologies - All Time High

Article By: Jim Van Meerten

Wednesday, July 8, 2015 3:22 PM EDT

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut.

In this article: DBVT

Read